V. Chantada

A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

Antonio Ojea, José Luís Nogueira, Eduardo Solsona et al. · European Urology · 2007 · 204 citations

Urology, Surgical Oncology, Genitourinary Cancer +6

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

Luis Martínez‐Piñeiro, José Antonio Portillo, J.M. Fernández Gómez et al. · European Urology · 2015 · 76 citations · Full text

Urological Research, Surgical Oncology, Urology +8

Sequential Combination of Mitomycin C Plus Bacillus Calmette-Guérin (BCG) Is More Effective but More Toxic Than BCG Alone in Patients with Non–Muscle-invasive Bladder Cancer in Intermediate- and High-risk Patients: Final Outcome of CUETO 93009, a Randomized Prospective Trial

Eduardo Solsona, Rosário Madero, V. Chantada et al. · European Urology · 2014 · 70 citations · Full text

Surgical Oncology, Urology, Genitourinary Cancer +7

Renal transplantation with venous drainage through the superior mesenteric vein in cases of thrombosis of the inferior vena cava

Javier Aguirrezabalaga, S. Novás, Francisco Gómez Veiga et al. · Transplantation · 2002 · 49 citations

Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival

René Mager, Siamak Daneshmand, Christopher P. Evans et al. · Journal of Surgical Oncology · 2016 · 34 citations · Full text